Express Scripts Holding Company (NASDAQ:ESRX) closed its last session at $80.09. The stock traded within a range of $79.88 and $81.04. The company operates in the Healthcare sector with a market capitalization of 45.4 Million. Trading volume for Express Scripts Holding Company was 5.05 Million in its previous trading session. Currently, Express Scripts Holding Company (NASDAQ:ESRX) has an average volume of 4.13 Million.
Express Scripts Holding Company operates as a pharmacy benefit management (PBM) company. It operates in two segments, PBM and Other Business Operations. The PBM segment offers clinical solutions, specialized pharmacy care, home delivery and specialty pharmacy, retail network pharmacy administration, benefit design consultation, drug utilization review, drug formulary management, administration of a group purchasing organization, and consumer health and drug information services. This segment also provides Medicare, Medicaid, health insurance marketplace products etc. The Other Business Operations segment distributes pharmaceuticals and medical supplies, including injectable and infusible pharmaceuticals and medications to treat specialty and rare/orphan diseases. This segment also provides consulting services, such as design, implementation, and project management for pharmaceutical and biotechnology manufacturers to collect scientific evidence to guide the use of medicines.
Express Scripts Holding Company (NASDAQ:ESRX) received a Buy rating from 1 analysts. 1 analysts gave its stock an Outperform rating. 6 analysts say it’s a Hold while 0 analysts provided their expert opinion as Sell.
Express Scripts Holding Company (NASDAQ:ESRX) touched its 1-Year High price of $81.04 on 01/11/18 and its 1-Year Low price of $55.80 on 10/18/17.
EPS & Financials
Express Scripts Holding Company (NASDAQ:ESRX) reported its EPS in the last quarter as $1.9/Share lagging the analyst estimate of $1.9/Share by a difference of $0. This showed a surprise of 0% in the last quarter earnings.
For the current quarter, 19 analysts are projecting a mean EPS of $2.08/share. According to their observations and findings, the stock could provide a high EPS of $2.14/share and a low EPS of $1.97/share.
Analysts believe that the company has the potential to earn average revenue of $25.1 Billion for the current quarter. According to their predictions high & low revenue estimates are 25.59 Billion and 24.18 Billion respectively.
By taking a look at the stock’s current statistics it can gauged that the stock candle is BEARISH with HIGH volatility. Express Scripts Holding Company (NASDAQ:ESRX) has a 20-Day average volume of 4.05 Million. According to today’s trading volume Express Scripts Holding Company is ABOVE its 20-Day Avg. volume with the stock showing ABOVE Abnormal volume in the past 150 days.
Moving average convergence divergence (MACD) shows that the stock is on a PRICE RELATIVITY trend. The trend for the past 10-days shows that the company was in BULLISH territory while an analysis of the last 40-Day trend shows a BULLISH signal. The 100-Day trend also shows a BULLISH trend as well.
The company currently has an insider ownership of 0.1 Percent and Institutional ownership of 90.6 Percent. The return on assets stands at 7.1%, Return on Equity currently is 22.7% and the Return on Investment value is 12.9%.
Express Scripts Holding Company (NASDAQ:ESRX) gross margin percentage stands at 8.6% while its operating margin for the past trailing twelve month is 5.4 percent and its overall profit margin (ttm) is 3.6 Percent. The stock is currently moving above its 20-Day Simple Moving Average of 7.72% with a 50-Day Simple Moving Average of 18.77 percent. As of today, the company has a SMA200 (200-day simple moving average) of 26.09 Percent. The Stock has YTD (year to date) performance of 7.3 percent.
The TTM operating margin for the company stands at 5.4%. The return on invested capital is at 12.9%, which is good, compared to its peers. The Free Cash Flow or FCF margin is 7.62.
The company’s stock is currently moving with a +ve distance from the 200 day SMA of approximately 26.09%, and has a solid year to date (YTD) performance of 7.3% which means that the stock is constantly adding to its value from the previous fiscal year end price.